Interestingly, the dual agonist tirzepatide has shown efficacy in neuroprotection, by counteracting hyperglycemia and insulin resistance-related effects at the neuronal level ( Also triple agonists have demonstrated to possess anti-neurodegenerative properties, indicating a potential for treating Alzheimers disease by reducing neuroinflammation and oxidative stress, enhancing neuronal health and viability, and minimizing glutamate excitotoxicity (Kopp et al., 2022)
To support consistent maintenance and results, we also offer a package of five drips with the fifth one free
Results Sema ameliorates myocardial hypertrophy and cardiac dysfunction induced by TAC for eight weeks in mice To investigate the effect of Sema on pathological cardiac remodeling, after TAC or sham surgery, we administered different doses (4 g/kg, 12 g/kg, and 60 g/kg) of Sema or vehicle to mice every day for eight weeks (Fig
Accelerated Rapid Release Formula